TAVOLIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 16:56:28 GMT 2023` Edited by `admin` on `Sat Dec 16 16:56:28 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	4LU9B48U4D
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TAVOLIMAB

Official Name

English

TAVOLIMAB [USAN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSTNFRSF4 (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 4, OX40, CD134)), HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODY GAMMA1 HEAVY CHAIN (1-451) (CHIMERIC VH (MUS MUSCULUS IGHV3-8*02 -(IGHD)-HOMO SAPIEN

Common Name

English

Tavolimab [WHO-DD]

Common Name

English

tavolimab [INN]

Common Name

English

MEDI0562

Code

English

TAVOLIXIZUMAB

Official Name

English

MEDI 0562 [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD134 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL MEDI0562 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MEDI0562 .KAPPA.-CHAIN, DIMER

Common Name

English

MEDI-0562

Code

English

Code System Code Type Description

INN

10420

Created by admin on Sat Dec 16 16:56:28 GMT 2023 , Edited by admin on Sat Dec 16 16:56:28 GMT 2023

PRIMARY

NCI_THESAURUS

C120041

Created by admin on Sat Dec 16 16:56:28 GMT 2023 , Edited by admin on Sat Dec 16 16:56:28 GMT 2023

PRIMARY

CAS

1635395-25-3

Created by admin on Sat Dec 16 16:56:28 GMT 2023 , Edited by admin on Sat Dec 16 16:56:28 GMT 2023

PRIMARY

FDA UNII

4LU9B48U4D

Created by admin on Sat Dec 16 16:56:28 GMT 2023 , Edited by admin on Sat Dec 16 16:56:28 GMT 2023

PRIMARY

USAN

CD-168

Created by admin on Sat Dec 16 16:56:28 GMT 2023 , Edited by admin on Sat Dec 16 16:56:28 GMT 2023

PRIMARY

DRUG BANK

DB15042

Created by admin on Sat Dec 16 16:56:28 GMT 2023 , Edited by admin on Sat Dec 16 16:56:28 GMT 2023

PRIMARY

From	To
1_22	1_95
1_148	1_204
1_265	1_325
1_371	1_429
1_224	3_214
2_224	4_214
1_230	2_230
1_233	2_233
2_22	2_95
2_148	2_204
2_265	2_325
2_371	2_429
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_301
N	2_301

Related Record Type Details


					115VXA358P

TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4

TARGET -> AGONIST

Related Record Type Details


					4LU9B48U4D

TAVOLIMAB

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL